TLDR
- First quarter revenue reached $5.43 billion, surpassing the $4.57 billion estimate by 18.6%
- Adjusted earnings per share of $1.32 exceeded the $1.25 analyst consensus by 5.9%
- Pricing increases compensated for declining shipment volumes, driving revenue expansion
- Marlboro’s overall cigarette market share declined by 1.4 percentage points
- Full-year adjusted EPS forecast remains unchanged at $5.64 midpoint
The tobacco giant delivered an impressive first quarter performance, surpassing analyst projections for both top-line revenue and bottom-line earnings. Altria announced quarterly sales of $5.43 billion, representing a 20.1% year-over-year increase and substantially exceeding the $4.57 billion Wall Street forecast.
The company’s adjusted earnings per share landed at $1.32, outperforming the consensus estimate of $1.25 by 5.9%. This represents a 7.3% year-over-year improvement in adjusted diluted EPS performance.
For the three months ending March 31, net income totaled $2.18 billion, translating to $1.30 per diluted share. This compares favorably against the prior year’s $1.08 billion, or 63 cents per share.
The company’s adjusted operating income reached $3.03 billion, exceeding the $2.83 billion forecast and delivering a 55.9% operating margin. This marks a significant improvement from the 39.6% margin recorded in the comparable quarter last year.
Strategic Pricing Drives Performance
The smokeable products division delivered strong results. Strategic price increases more than compensated for reduced shipment volumes and heightened promotional spending, enabling revenue expansion despite weaker consumer demand.
Similarly, oral tobacco products experienced revenue growth powered by price adjustments, even as shipment volumes contracted. This reflects Altria‘s established strategy — increase prices, accept lower volumes, while maintaining robust profit margins.
The company’s premier brand, Marlboro, experienced a 1.4 percentage point decline in total cigarette market share throughout the quarter. Nevertheless, Altria noted that Marlboro actually expanded its share within the premium cigarette category.
The company’s on! nicotine pouches saw market share slip by less than 1 percentage point. This product category represents a strategic growth initiative for Altria.
Full-Year Outlook Maintained Despite Headwinds
The tobacco company maintained its full-year adjusted EPS guidance with a midpoint of $5.64. Management noted that this unchanged forecast now incorporates expectations for slower e-vapor industry expansion than previously anticipated.
The company also acknowledged growing macroeconomic uncertainty affecting adult consumers as a factor incorporated into its updated outlook. Despite these challenges, Altria chose to maintain its original forecast.
Chief Executive Billy Gifford characterized the results as “a strong start to the year,” highlighting the 7.3% adjusted EPS expansion in the first quarter as confirmation that business operations are tracking as anticipated.
With a market capitalization approaching $114 billion, Altria ranks among the largest consumer staples companies traded publicly.
During the past 12 months, the company produced $21.05 billion in revenue — essentially unchanged from three years earlier, illustrating weak fundamental demand even as pricing strategies have remained effective.
Wall Street analysts currently forecast a 3.5% revenue contraction over the coming 12 months. This estimate captures continued volume headwinds affecting the broader tobacco sector.
While the company exceeded expectations on both revenue and earnings, volume dynamics continue presenting ongoing obstacles. Price increases have successfully offset these challenges thus far, though the sustainability of pricing power has natural limitations.
The company’s first quarter adjusted operating income of $3.03 billion surpassed analyst projections by 7.2%, highlighting Altria’s capability to preserve margins even amid challenging demand conditions.





